Drug Shortage Report for RIVA-PYRIDOSTIGMINE
Report ID | 212593 |
Drug Identification Number | 02495643 |
Brand name | RIVA-PYRIDOSTIGMINE |
Common or Proper name | Riva-Pyridostigmine 60mg |
Company Name | LABORATOIRE RIVA INC. |
Market Status | MARKETED |
Active Ingredient(s) | PYRIDOSTIGMINE BROMIDE |
Strength(s) | 60MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N07AA |
ATC description | PARASYMPATHOMIMETICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2023-12-15 |
Actual start date | |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2023-12-16 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 660 BOUL. INDUSTRIEL BLAINVILLE, QUEBEC CANADA J7C 3V4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2023-12-16 | English | Compare |
v2 | 2023-12-06 | French | Compare |
v1 | 2023-12-06 | English | Compare |
Showing 1 to 3 of 3